| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jan 25 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1 | 675,000 | 675.00 k | 675,000 |
| 13 Jan 25 | RGLS Regulus Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 1.2632 | 31,445 | 39.72 k | 36,055 |
| 9 Jan 25 | RGLS Regulus Therapeutics | Common Stock | Grant | Acquire A | No | No | 1.3 | 30,000 | 39.00 k | 67,500 |
| 9 Jan 25 | RGLS Regulus Therapeutics | Common Stock | Grant | Acquire A | No | No | 1.36 | 37,500 | 51.00 k | 37,500 |
| 20 May 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.01 | 528,000 | 1.06 mm | 528,000 |
| 12 Jan 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.3 | 120,000 | 156.00 k | 120,000 |
